Effective March 1, 2020, E. Jennifer Edelman, MD, MHS (pictured left), assumed the role of Director of CIRA's Clinical and Health Services Research (CHSR) Core, replacing David Fiellin, MD who served as the CHSR Core Director since 2018. Dr. Edelman's research focuses on optimizing HIV prevention and treatment in the context of substance use, including opioid, alcohol and tobacco use. She leads and collaborates on NIH-funded projects to evaluate novel and implement evidence-based addiction treatment in medical settings and partners with community-based providers and public health practitioners to promote HIV prevention, including use of pre-exposure prophylaxis (PrEP) and partner services.
We thank Dr. Fiellin for his long dedication to CIRA. Prior to assuming leadership of the CHSR Core in May 2018, Dr. Fiellin was the Director of CIRA's Community Research and Implementation (CRI) Core (2009-2018) and Associate Director of the CHSR Core (2008-2014). Dr. Fiellin will remain affiliated with CIRA while continuing his research and medical efforts and serving as the inaugural Director of the Yale Program in Addiction Medicine.
Published: Monday, March 9, 2020
